CDISC Data Standards Validation

Size: px
Start display at page:

Download "CDISC Data Standards Validation"

Transcription

1 CDISC Data Standards Validation How can it be done? Peter Van Reusel Business Unit Director Business & Decision Life Sciences Tel Fax Mobile peter.vanreusel@businessdecision.com Sint-Lambertusstraat 141 Rue Saint- Lambert 1200 Brussels

2 Topics 1 Current Situation 2 Applied CDISC Compliance 3 Summary

3 Topics 1 Current Situation 2 Applied CDISC Compliance 3 Summary

4 FDA Submissions (1) It is requested to submit clinical trial data (SDTM) & metadata (Define.xml) according to the SDTMIG V3.1.2 standards It is highly recommended to submit analysis data (ADaM) and metadata (Define.xml) according to the ADaMIG V1.0 standards Data standards allow the FDA to use standard tools

5 FDA Submissions (2) Applies to both FDA CBER and FDA CDER (Study Data Specifications) nrequirements/electronicsubmissions/ucm pdf CBER has recently released new documentation for submitting data to CBER (Submision of data in CDISC format to CBER) Office of Vaccines Research and Review May 15, 2010 Office of Blood Research and Review September 1, 2010 Office of Cellular and Gene Therapies December htm CDER has prepared a Data Standards Plan which will be released to the public soon nrequirements/electronicsubmissions/ucm pdf

6 SDTM FDA Tools: Patient Profile Viewer

7 SDTM FDA Tools: JReview (1)

8 SDTM FDA Tools: JReview (2) v3.1 Training Materials

9 SDTM FDA Tools: WebSDM (1) v3.1 Training Materials

10 SDTM FDA Tools: WebSDM (2)

11 SDTM FDA Tools: WebSDM (3)

12 CDISC Data Model Conformance (SDTM & ADaM) Follow complete metadata structure Follow CDISC domain models Include all Required and Expected variables Use CDISC-specified: standard domain names and prefixes standard variable names variable labels (SDTM only) data types for all variables (SDTM only) controlled terminology and format guidelines Currently, adhere to the SAS V5 XPT limitations Ensure that each dataset includes a set of keys Ensure that each record in a dataset includes a topic variable (SDTM only) Conform to all business rules

13 Results of non-compliance Not following data standards will: break the tools create confusion and frustration give the impression that the sponsor does not control the data

14 Current status (1) Validation check history WebSDM (1.5, 2.6, 3.0), SDTMIG (3.1, 3.1.1, 3.1.2), ADaMIG (1.0) Today, different vendors have developed a specific tool WebSDM Data Model Compliance Checker Validator Checkpoint Clinical Standards Toolkit

15 Current status (2) Different vendors have created different checks Different tools are producing different output Rules and checks are not clearly defined There is no official version yet

16 Current status (3) ADaM team: Has published ADaMIG V1.0 ( Dec. 17, 2009) Has developed a draft check list (June 11, 2010) Is preparing a final version SDTM team did not create a check list CDISC has started the CAB VP CDISC Advisory Board Validation Project To create one official version of the SDTM checks Broad industry representation Representing all of the 5 major vendors and the FDA

17 Current status (4) Ongoing comparison and consolidation between all checks Unambiguous check specification will avoid check interpretation

18 FDA CRT Submission Process (1) Data Tabulation Components: SDTM annotated CRFs SDTM datasets ADaM datasets Define.xml metadata

19 FDA CRT Submission Process (2) WebSDM and OpenCDISC tools check the CDISC SDTM data & metadata to ensure standard FDA tools can be used

20 FDA CRT Submission Process (3) CDISC SDTM (& ADaM) compliance issues are reported to the sponsor

21 Janus layers Source: «CDISC Standards, Present & Future», Dave Iberson-Hurst, CDISC, VP Technical Strategy

22 SDTM Compliance Issues Report OBPS provides an SDTM issue list to the sponsor OBPS = Office of Business Process Support Loading issues can be caused by Data & Metadata Inconsistency Non conformity with:» SDTM Model» SDTM IG business rules» Controlled Terminology

23 Topics 1 Current Situation 2 Applied CDISC Compliance 3 Summary

24 CDISC Compliance Checks We have created an expanded & enhanced list of checks 154 WebSDM checks Total check package: SDTMIG V3.1.1 SDTMIG V3.1.2 ADaMIG V1.0 Data checks Metadata checks Mapping checks Project consistency checks CDISC compliance checks list is growing continuously

25 Categorization CDISC Compliance Checks Categories Data Metadata Class Domain Mapping Timing variables Data model version Check version

26 Application Flowchart Metadata definition of the data model or sponsor proprietary data standards + CDISC controlled terminology

27 Application Flowchart The data model compliance checks system reads the folder with the SDTM, ADaM datasets & the define.xml metadata file

28 Application Flowchart DEFINE.XML SDTM DATASETS ADaM DATASETS DATA & METADATA ENVIRONMENT METADATA DATABASE CHECK SCHEDULER EXCEPTION TABLE SDTMIG V3.1.1 SDTMIG V3.1.2 ADaMIG V1.0 METADATA LIBRARY Metadata Cross Checks DEFINED JOB CHECK SELECTION SDTM COMPLIANCE ISSUE REPORT Data Model Compliance Checks cross-check for consistency between: CDISC SDTM or ADaM datasets definition Metadata reported in the Define.xml CDISC SDTM, ADaM or sponsor proprietary data standards in the metadata library

29 Application Flowchart A job definition is created in the application interface

30 Application Flowchart Identified quality issues are added to an exception table Quality check reports are generated for further processing

31 Application Interface

32 Application Interface Data Model Selection Screen Select Data Model Possibility to add proprietary data models Select Controlled Terminology CDISC Controlled Terminology Possibility to include sponsor-defined controlled terminology

33 Application Interface

34 Application Interface Job Creation Screen Check Selection : Select Project and Study Select Checks based on Class Events, Interventions, Findings, Trial Design, Special Purpose, Findings About Type Data, Metadata, Programming Individual Select from dynamically created list of domains Creates Job ID Check Description : Detailed description of all checks Possibility of adding/modifying check descriptions

35 Application Interface Check Selection :

36 Application Interface Check Description:

37 Application Interface Run Job Screen Job List :» Lists Job ID, Job description, Job owner, Job creation date» Select the job to run Job Description :» Lists project and studyid for the selected job» Lists checks to run for the selected job» Lists domains on which selected checks run

38 Application Interface Job List

39 Application Interface Job Description

40 Application Interface Parameter Database Central table for project and study parameters

41 Reporting Tool (1) 3 reports are created: Exception log Exception summary Exception report > 50 exceptions per check per domain: only 3 exceptions are reported

42 Reporting Tool (2) 3 reports are created: Exception log Exception summary Exception report > 50 exceptions per check per domain: only 3 exceptions are reported

43 Reporting Tool (3) 3 reports are created: Exception log Exception summary Exception report > 50 exceptions per check per domain: only 3 exceptions are reported Reported Exception Record Identifiers Exception Attributes

44 Topics 1 Current Situation 2 Applied CDISC Compliance 3 Summary

45 Summary CDISC compliance will facilitate: The use of the FDA tools In-house communication between CRO and sponsors Running these checks do not necessarily solve all findings but sponsor is prepared for FDA feedback Document confirmed issues in FDA Reviewers Guide CBER calls this the Validation and Data Interpretation Report FDA will not reject your submission (yet)!

46

47 Thank you for your attention Peter Van Reusel Business Unit Director Business & Decision Life Sciences Tel Fax Mobile peter.vanreusel@businessdecision.com Sint-Lambertusstraat 141 Rue Saint- Lambert 1200 Brussels

The Evolution of SDTM

The Evolution of SDTM The Evolution of SDTM What s new? Tina Apers CRO Manager Mobile +32 476 60 08 79 tina.apers@businessdecision.com Business & Decision Life Sciences Tel +32 2 774 11 00 Fax +32 2 774 11 99 Sint-Lambertusstraat

More information

Standardize Study Data for Electronic Submission

Standardize Study Data for Electronic Submission PharmaSUG China 2018 - Paper CD-43 ABSTRACT Standardize Study Data for Electronic Submission Qin Li, Regeneron Pharmaceuticals Inc. In December 2014, FDA announced that submissions under NDAs, ANDAs, BLAs,

More information

SAS Drug Development in action: efficient standards libraries and study management modules together called CDmation.

SAS Drug Development in action: efficient standards libraries and study management modules together called CDmation. SAS Drug Development in action: efficient standards libraries and study management modules together called CDmation. Mark Lambrecht (SAS) Peter Van Reusel (Business & Decision Life Sciences) The clinical

More information

SAS SUPPORT CDISC AND CLINICAL METADATA MANAGEMENT BILL GIBSON SAS HLS GLOBAL PRACTICE PRINCIPAL PRODUCT MANAGER

SAS SUPPORT CDISC AND CLINICAL METADATA MANAGEMENT BILL GIBSON SAS HLS GLOBAL PRACTICE PRINCIPAL PRODUCT MANAGER SAS SUPPORT CDISC AND CLINICAL METADATA MANAGEMENT BILL GIBSON SAS HLS GLOBAL PRACTICE PRINCIPAL PRODUCT MANAGER OVERVIEW AND INTRODUCTION Abstract: SAS s current and future support of CDISC, such as possible

More information

Conformance Rules how to follow and comply when specified by multiple sources?

Conformance Rules how to follow and comply when specified by multiple sources? Conformance Rules 05-Nov-2018 1 Conformance Rules how to follow and comply when specified by multiple sources? PhUSE EU Connect 2018 Francis Dsa Agenda Conformance Rules 05-Nov-2018 2 Different sources

More information

CDISC End-to-End UK User Group Meeting GSK, Stockley Park 24 th October 2007 Dave Iberson-Hurst CDISC VP Technical Strategy CDISC 2007 Dave Iberson-Hurst CDISC VP Technical Strategy Co-lead Technical Advisory

More information

Evolving Regulatory Guidance on Submission of Standardized Data. James R. Johnson, PhD RTP CDISC User Network

Evolving Regulatory Guidance on Submission of Standardized Data. James R. Johnson, PhD RTP CDISC User Network Evolving Regulatory Guidance on Submission of Standardized Data James R. Johnson, PhD RTP CDISC User Network 2014-06-11 Originally Presented at PhUSE Conference 2013 Brussels, Belgium (Paper Number: RG03)

More information

Supporting A Data Review and Visualization Application With SDTM

Supporting A Data Review and Visualization Application With SDTM Paper DV09 Supporting A Data Review and Visualization Application With SDTM Deepika Sunkara, MS, Covance, King of Prussia, Pennsylvania Jagadish Dhanraj, MS, Medimmune, Gaithersburg, Maryland ABSTRACT

More information

October, Integration and Implementation of CDISC Standards

October, Integration and Implementation of CDISC Standards Integration and Implementation of CDISC Standards October, 2008 Barbara Lentz, Associate Director, Electronic Data Management Standards, Processes & Training Pat Majcher, Statistical Reporting Services

More information

SDTM and SEND An Integrated View and Approach

SDTM and SEND An Integrated View and Approach SDTM and SEND An Integrated View and Approach PhUSE Connect 2018 Veena Nataraj Cheryl Riel Overview Nonclinical and Clinical Development Phase Regulatory Agency Needs Deliverables to Regulatory Agencies

More information

The Evolution of SDTM What s new

The Evolution of SDTM What s new Paper CD10 The Evolution of SDTM What s new Tina Apers, Business & Decision Life Sciences, Brussels, Belgium ABSTRACT In July 2012 CDISC released the final version of SDTM V1.3 and SDTMIG V3.1.3. This

More information

CDISC Standards: Current and Future

CDISC Standards: Current and Future CDISC 2010 CDISC Standards: Current and Future CDISC Japan Interchange Tokyo, Japan 20 July 2010 Rebecca D. Kush, PhD President and CEO, CDISC Clinical Research Standards (Content) (Protocol-driven Research;

More information

Clinical Data Standards & Automation

Clinical Data Standards & Automation Clinical Data Standards & Automation PhUSE 2007 Author: Giri Balasubramanian Company Name: Kinship Technologies Pvt. Ltd., Table of Contents EXECUTIVE SUMMARY... 3 1.0 INTRODUCTION... 4 2.0 WHY AUTOMATION?...

More information

CDISC Italian UN Aggiornamento/Attività

CDISC Italian UN Aggiornamento/Attività CDISC Italian UN Aggiornamento/Attività CDISC Italian User Network Day 27 Ottobre 2017 Angelo Tinazzi (Cytel) - Silvia Faini (CROS NT) E3C members 2 Agenda Risposte Questionario Partecipanti CDISC in a

More information

DISCOVER DEFINE- XML PRACTICAL USES END-TO-END TODAY Mark Wheeldon CEO Formedix Bay Area User Group May 23, 2013

DISCOVER DEFINE- XML PRACTICAL USES END-TO-END TODAY Mark Wheeldon CEO Formedix Bay Area User Group May 23, 2013 DISCOVER DEFINE- XML PRACTICAL USES END-TO-END TODAY Mark Wheeldon CEO Formedix Bay Area User Group May 23, 2013 AGENDA Introduction Your Clinical Trials Automated. Everywhere. Define Driven Dataset Libraries

More information

From Standards that Cost to Standards that Save: Cost Effective Standards Implementation

From Standards that Cost to Standards that Save: Cost Effective Standards Implementation From Standards that Cost to Standards that Save: Cost Effective Standards Implementation Jeffrey M. Abolafia, Rho, Chapel Hill, NC Frank DiIorio, CodeCrafters Inc., Philadelphia, PA Warning This presentation

More information

PharmaSUG Paper IB15

PharmaSUG Paper IB15 PharmaSUG 2016 - Paper IB15 Importance of Niche Provider for Successful NDA Submission: Rescue Case Study Aparna Poona, Vita Data Sciences, Waltham, MA Bhavin Busa, Vita Data Sciences, Waltham, MA Tim

More information

CDISC Production Standards Status & Plans

CDISC Production Standards Status & Plans Bay Area User Network CDISC Production Standards Status & Plans Wayne R. Kubick Sr. Vice President, Lincoln Technologies CDISC Technical Director SDS Team Leader Agenda Topics The role and work of the

More information

Using SAS ETL Studio to Convert Clinical Trials Data to the CDISC SDTM Barry R. Cohen, Octagon Research Solutions, Wayne, PA

Using SAS ETL Studio to Convert Clinical Trials Data to the CDISC SDTM Barry R. Cohen, Octagon Research Solutions, Wayne, PA Paper FC04 Using SAS ETL Studio to Convert Clinical Trials Data to the CDISC SDTM Barry R. Cohen, Octagon Research Solutions, Wayne, PA ABSTRACT A new industry standard for clinical and preclinical trials

More information

2016 Technical Update. August 2016

2016 Technical Update. August 2016 2016 Technical Update August 2016 1 Foundational Standards Key Milestones CTR ODM XML Modernize CT Process CDISC Protocol Standards IntraChange Cross-team focus Survey CTR Content Governance: Consistent

More information

Authoring Considerations for Creating PhUSE Study Data Standardization Plan (SDSP) and CBER Appendix

Authoring Considerations for Creating PhUSE Study Data Standardization Plan (SDSP) and CBER Appendix Authoring Considerations for Creating PhUSE Study Data Standardization Plan (SDSP) and CBER Appendix PhUSE US Connect June 2018 Janet Low, Merck & Co., Inc., North Wales, PA, US Pritesh Solanki, Merck

More information

Janus Clinical Trials Repository: Modernizing the Review Process through Innovation

Janus Clinical Trials Repository: Modernizing the Review Process through Innovation Janus Clinical Trials Repository: Modernizing the Review Process through Innovation Lilliam Rosario, Ph.D. Director Office of Computational Science Food and Drug Administration Janus Clinical Trials Repository

More information

XClinical Software & Services Fast - Flexible - Focused

XClinical Software & Services Fast - Flexible - Focused Fact Sheets XClinical Software & Services Fast - Flexible - Focused XClinical offers an integrated range of software products for CROs, pharmaceutical, medical device and biopharmaceutical companies. Our

More information

CDASH Clinical Data Acquisition Standards Harmonization

CDASH Clinical Data Acquisition Standards Harmonization CDISC Italian User Group Meeting 16 November 2007 CDASH Clinical Data Acquisition Standards Harmonization 1 Outline Background Organization Goals Timelinesand Process Review of progress Results Future

More information

CDISC/TransCelerate Collaboration and TransCelerate work streams. -Clinical Data Standards -Common Protocol Template -esource

CDISC/TransCelerate Collaboration and TransCelerate work streams. -Clinical Data Standards -Common Protocol Template -esource CDISC/TransCelerate Collaboration and TransCelerate work streams -Clinical Data Standards -Common Protocol Template -esource July 2016 TransCelerate Clinical Data Standards Project Opportunity

More information

Industrialized Clinical Data Standards Management Speed of automation, Power of accuracy and Transforming clinical data into business intelligence

Industrialized Clinical Data Standards Management Speed of automation, Power of accuracy and Transforming clinical data into business intelligence Industrialized Clinical Standards Management Speed of automation, Power of accuracy and Transforming clinical data into business intelligence Executive Summary The majority of commercially available legacy

More information

DRIVING CLINICAL DATA STANDARDS BEYOND COMPLIANCE

DRIVING CLINICAL DATA STANDARDS BEYOND COMPLIANCE SMARTER DRUG DEVELOPMENT DRIVING CLINICAL DATA STANDARDS BEYOND COMPLIANCE Binding FDA requirements take effect in 2016 will your data standards platform do more than simply comply? INTRODUCTION In December

More information

SAS End-to-End solutions in Clinical Trial Emma Liu, SAS R&D, Beijing, China

SAS End-to-End solutions in Clinical Trial Emma Liu, SAS R&D, Beijing, China PharmaSUG China 2015 - Paper 29 SAS End-to-End solutions in Clinical Trial Emma Liu, SAS R&D, Beijing, China ABSTRACT Are you in trouble with executing timely queries against historical or ongoing clinical

More information

Approaches and Challenges in Implementing CDISC Standards DC DCISC User Group Meeting

Approaches and Challenges in Implementing CDISC Standards DC DCISC User Group Meeting Approaches and Challenges in Implementing CDISC Standards DC DCISC User Group Meeting 2007-09-13 Musa Nsereko, BDS MPH Sr. Manager, Clinical Data Programming Cephalon, Inc. Member CDISC SDS Team Co-leader

More information

End-to-End Management of Clinical Trials Data

End-to-End Management of Clinical Trials Data End-to-End Management of Clinical Trials Data A Revolutionary Step Toward Supporting Clinical Trials Analysis Over the Next Decades of Clinical Research WHITE PAPER SAS White Paper Table of Contents Introduction....

More information

FDASmart Inc. EDC & CDM Solutions

FDASmart Inc. EDC & CDM Solutions FDASmart Inc. EDC & CDM Solutions Our Services Validation of EDC Products as per Client Requirement with compliance with FDA s CFR 21 Part 11 Training on EDC Rave Helps to prepare SOPs and SWIs related

More information

Welcome to the American College of Toxicology s Webinar Series. We will begin at 11AM EDT

Welcome to the American College of Toxicology s Webinar Series. We will begin at 11AM EDT Welcome to the American College of Toxicology s Webinar Series We will begin at 11AM EDT Preparing for Nonclinical edata Regulatory Submissions to the US FDA SEND and Beyond September 5, 2013, 11:00 AM

More information

Advanced workflow of review/consultation

Advanced workflow of review/consultation PMDA Update Yuki Ando, PhD Senior Scientist for Biostatistics Advanced Review with Electronic Data Promotion Group Pharmaceuticals and Medical Devices Agency CDISC 2016 1 Advanced workflow of review/consultation

More information

Steps and Slides of Implementing Global Standards Producing High Quality Programming Outputs Edition

Steps and Slides of Implementing Global Standards Producing High Quality Programming Outputs Edition Steps and Slides of Implementing Global Standards Producing High Quality Programming Outputs Edition David Izard, MS Terek Peterson, MBA Richard Addy, MS CDISC ODM SDTM LAB CDASH ADaM PRM SEND Controlled

More information

Clinical Data Standards Governance. Tammy Burns, Expert Clinical Data Manager 11 th January 2013

Clinical Data Standards Governance. Tammy Burns, Expert Clinical Data Manager 11 th January 2013 Clinical Data Standards Governance Tammy Burns, Expert Clinical Data Manager 11 th January 2013 Standards Used and Formal Govenance Standard Types General and Therapeutic Area Data Standards Collection

More information

NEW AGILE CLINICAL TRIALS SUCH AS ADAPTIVE DESIGNS AND THE USE OF THE SAS LIFE SCIENCE ANALYTICAL FRAMEWORK

NEW AGILE CLINICAL TRIALS SUCH AS ADAPTIVE DESIGNS AND THE USE OF THE SAS LIFE SCIENCE ANALYTICAL FRAMEWORK NEW AGILE CLINICAL TRIALS SUCH AS ADAPTIVE DESIGNS AND THE USE OF THE SAS LIFE SCIENCE ANALYTICAL FRAMEWORK DR. MARK LAMBRECHT, ADVISORY INDUSTRY CONSULTANT SAS HEALTH AND LIFE SCIENCES GLOBAL PRACTICE

More information

Electronic Data Submission and Utilization in Japan

Electronic Data Submission and Utilization in Japan PharmaSUG 2018 April 29 - May 2, Seattle, Washington Electronic Data Submission and Utilization in Japan Yuki Ando, PhD Senior Scientist for Biostatistics Office of Advanced Evaluation with Electronic

More information

2010 CDISC Japan Interchange

2010 CDISC Japan Interchange 2010 6 28 2010 CDISC Japan Interchange Japan CDISC Coordinating Committee (J3C) Chair 2010 7 20 7 23 4 7 20 21 7 22 23 102-0093 2-4-1 Tel 03-3265-8211 http://www.toshicenter.co.jp CDISC http://www.cdisc.org/interchange

More information

Preclinical Data Standardization Process for regulatory submission to U.S. Food and Drug Administration

Preclinical Data Standardization Process for regulatory submission to U.S. Food and Drug Administration Preclinical Data Standardization Process for regulatory submission to U.S. Food and Drug Administration Gabriele Pesavento, 23 May 2018 Aptuit An Evotec company A full service CRO that delivers purpose

More information

Implementing Clinical Trial Data Standards

Implementing Clinical Trial Data Standards Bernd Doetzkies, Director Informatics Daiichi Sankyo Pharma Development PRISME Forum SIG Meeting 17Oct2011 Implementing Clinical Trial Data Standards Clinical Development Business Trends Resistance to

More information

MANAGING AND ANALYZING CLINICAL DATA MARK LAMBRECHT, PRINCIPAL INDUSTRY CONSULTANT, SAS BIAS MEETING, MARCH 14 TH 2014, MILAN, ITALY.

MANAGING AND ANALYZING CLINICAL DATA MARK LAMBRECHT, PRINCIPAL INDUSTRY CONSULTANT, SAS BIAS MEETING, MARCH 14 TH 2014, MILAN, ITALY. MANAGING AND ANALYZING CLINICAL DATA MARK LAMBRECHT, PRINCIPAL INDUSTRY CONSULTANT, SAS BIAS MEETING, MARCH 14 TH 2014, MILAN, ITALY. TABLE OF CONTENTS SAS and CDISC Clinical trial challenges The promise

More information

Breakout session notes CDISC UK Network Face to Face meeting June 23 rd 2015

Breakout session notes CDISC UK Network Face to Face meeting June 23 rd 2015 Breakout session notes CDISC UK Network Face to Face meeting June 23 rd 2015 Questions that came up during the breakout sessions are colour-coded: Blue questions that were answered during the session,

More information

ADaM 2018: What s New and What s Coming. Jack Shostak, Duke Clinical Research Institute Sandra Minjoe, PRA

ADaM 2018: What s New and What s Coming. Jack Shostak, Duke Clinical Research Institute Sandra Minjoe, PRA ADaM 2018: What s New and What s Coming Jack Shostak, Duke Clinical Research Institute Sandra Minjoe, PRA 05.22.2018 Agenda 1. Update on ADaM subteams 2. Documents summary 3. ADaM future plans Subteam

More information

CDISC Global Update. President and CEO, CDISC

CDISC Global Update. President and CEO, CDISC CDISC Global Update Rebecca D. Kush, PhD President and CEO, CDISC CDISC Advisory Board Program Committee CherylSimon* Peter Van Reusel* Gary Walker* Marcelina Hungria Dave Handelsman* Patrick Genyn* Sharon

More information

SAS Life Science Analytics Framework

SAS Life Science Analytics Framework CDISC Italian User Network Day 21Oct2016 (Data standard e loro applicazione) SAS Life Science Analytics Framework STIJN ROGIERS - SAS SENIOR INDUSTRY CONSULTANT GLOBAL PRACTICE, HEALTH & LIFE SCIENCES

More information

INTRODUCING CLINIC AUTOMATION IN A PHASE I UNIT WITH END-TO-END E-SOURCE DATA PROCESSING

INTRODUCING CLINIC AUTOMATION IN A PHASE I UNIT WITH END-TO-END E-SOURCE DATA PROCESSING INTRODUCING CLINIC AUTOMATION IN A PHASE I UNIT WITH END-TO-END E-SOURCE DATA PROCESSING Wim Verreth 4 th Annual Outsourcing in Clinical Trials 21-22 May 2014 OUTLINE What is Clinical Automation? Why we

More information

PhUSE Paper PP07. EPOCH in Reverse. Ann Croft, LEO Pharma, Hurley, UK

PhUSE Paper PP07. EPOCH in Reverse. Ann Croft, LEO Pharma, Hurley, UK Paper PP07 EPOCH in Reverse Ann Croft, LEO Pharma, Hurley, UK ABSTRACT After supplying test data through the electronic gateway to the FDA, LEO Pharma was informed that the FDA required some updates to

More information

Implementation and Operation of CDISC ODM-based EDC by UMIN

Implementation and Operation of CDISC ODM-based EDC by UMIN Implementation and Operation of CDISC ODM-based EDC by UMIN Takahiro Kiuchi, M.D., Ph.D. UMIN Center, The University of Tokyo Hospital, Tokyo, Japan 1 Content 1. CDISC standards and academic research 2.

More information

CDISC Controlled Terminology: Let s Speak the Same Language

CDISC Controlled Terminology: Let s Speak the Same Language CDISC Controlled Terminology: Let s Speak the Same Language DCDISC User Network November 8, 2011 Chris Tolk Director, Terminology Agenda Overview / Objectives Key Drivers Terminology Development SDTMIG

More information

TransCelerate BioPharma, Inc. Clinical Data Standards Project. Dave Jordan Data Standards Project Leader

TransCelerate BioPharma, Inc. Clinical Data Standards Project. Dave Jordan Data Standards Project Leader TransCelerate BioPharma, Inc. Clinical Data Standards Project Dave Jordan Data Standards Project Leader 1 Outline TransCelerate Overview CFAST Overview Therapeutic Area Standards Project CDISC SHARE Q

More information

CDISC Tech Webinar Leveraging CDISC Standards to Drive Crosstrial Analytics; Graph Technology and A3 Informatics 26 OCT 2017

CDISC Tech Webinar Leveraging CDISC Standards to Drive Crosstrial Analytics; Graph Technology and A3 Informatics 26 OCT 2017 CDISC Tech Webinar Leveraging CDISC Standards to Drive Crosstrial Analytics; Graph Technology and A3 Informatics 26 OCT 2017 CDISC 2017 1 Panelists Jim LaPointe Managing Director, Cambridge Semantics Patrick

More information

PharmaSUG 2017 Paper DS14

PharmaSUG 2017 Paper DS14 PharmaSUG 2017 Paper DS14 Considerations in Submitting Standardized Electronic Data Under the Animal Rule: The Use of SDTMIG and SENDIG Domains, and the Need for New Domains and Concepts Fred Wood, Accenture

More information

BIOMETRICS SERVICES ADVISORY DATA OFFICE UNBLINDING SECURE INDEPENDENT TEAM PROGRAM. ADaM TRAINER SAFETY SDTM COMPLIANT TA-EXPERTISE SDTM DATA

BIOMETRICS SERVICES ADVISORY DATA OFFICE UNBLINDING SECURE INDEPENDENT TEAM PROGRAM. ADaM TRAINER SAFETY SDTM COMPLIANT TA-EXPERTISE SDTM DATA BIOMETRICS SERVICES DELIVER UNBLINDED DATASETS TO IDMC SDTM-IG UNBLINDING ADVISORY QUALITY ON TIME DEDICATED DATA SECURE BOARD EMERGENCY PARTNERSHIPTEAM DATA OFFICE UNBLINDING INVESTINGEXPERTISE SHARING

More information

Roadmap for Managing Multiple CRO Vendors

Roadmap for Managing Multiple CRO Vendors PharmaSUG 2017 - Paper PO27 Roadmap for Managing Multiple CRO Vendors Veena Nataraj, Shire, Lexington, MA Karin LaPann, Shire, Lexington, MA ABSTRACT When working with CROs, the relationship established

More information

The Do's/Don'ts, An SDTM Validation Perspective. The should/shouldn't when explaining issues in the SDRG (Study Data Reviewer s Guide)

The Do's/Don'ts, An SDTM Validation Perspective. The should/shouldn't when explaining issues in the SDRG (Study Data Reviewer s Guide) PharmaSUG 2017 - Paper SS10 The Do's/Don'ts, An SDTM Validation Perspective. The should/shouldn't when explaining issues in the SDRG (Study Data Reviewer s Guide) Tom Guinter, Independent Consultant, Data

More information

The use of electronic Health Records in Clinical Research - The value of CDISC Standards

The use of electronic Health Records in Clinical Research - The value of CDISC Standards The use of electronic Health Records in Clinical Research - The value of CDISC Standards FH-Prof. Dr. Jozef Aerts University of Applied Sciences FH Joanneum Graz, Austria Who is Jozef Aerts? CDISC volunteer

More information

Harnessing the power of clinical data

Harnessing the power of clinical data Harnessing the power of clinical data Harnessing the power of clinical data Managing the data burden Life sciences companies are rich in data and gaining exponentially more clinical data all the time.

More information

CDISC Journal. Genzyme s GetSMART Program: Implementing Standards End-to-End

CDISC Journal. Genzyme s GetSMART Program: Implementing Standards End-to-End CDISC Journal Clinical Data Interchange Standards Consortium O ctober 2011 Genzyme s GetSMART Program: Implementing Standards End-to-End By Sue Dubman, Brooke Hinkson, Dana Soloff, David Fritsche and PK

More information

CDISC Controlled Terminology across the Clinical Trial Continuum. Bay Area Implementation Network 6 March 2008

CDISC Controlled Terminology across the Clinical Trial Continuum. Bay Area Implementation Network 6 March 2008 CDISC Controlled Terminology across the Clinical Trial Continuum Bay Area Implementation Network 6 March 2008 Bron Kisler Co-Founder / Director of Terminology CDISC Terminology Initiative Overview / Background

More information

REQUEST FOR PROPOSAL. Statistical Programing Expert Crohn s Disease Therapeutic Area User Guide. October 2018

REQUEST FOR PROPOSAL. Statistical Programing Expert Crohn s Disease Therapeutic Area User Guide. October 2018 REQUEST FOR PROPOSAL Statistical Programing Expert Crohn s Disease Therapeutic Area User Guide - SPONSOR: CDISC October 2018 1 Contents Executive Summary... 3 Project Description... 3 Task Description...

More information

CDISC Journal. Current status and future scope of CDISC standards. By Rebecca D. Kush, President and CEO, CDISC. 1. Introduction

CDISC Journal. Current status and future scope of CDISC standards. By Rebecca D. Kush, President and CEO, CDISC. 1. Introduction CDISC Journal Clinical Data Interchange Standards Consortium oc tober 2012 Current status and future scope of CDISC standards By Rebecca D. Kush, President and CEO, CDISC 1. Introduction In translational

More information

Optimizing Your Study Data Submissions to FDA Updates from CDER and CBER

Optimizing Your Study Data Submissions to FDA Updates from CDER and CBER This single PDF file contains the slides for all three presentations in the webinar: Optimizing Your Study Data Submissions to FDA Updates from CDER and CBER Please page down to find the slides for all

More information

Eileen Navarro MD, FACP Medical Officer, OCS, OTS, CDER, FDA

Eileen Navarro MD, FACP Medical Officer, OCS, OTS, CDER, FDA Eileen Navarro MD, FACP Medical Officer, OCS, OTS, CDER, FDA 1 www.fda.gov WHAT MEDICAL REVIEWERS CAN DO WITH STANDARDIZED DATA AND METADATA RECEIVED IN MODULE 5 Eileen Navarro, MD, FACP OCS/OTS/CDER/FDA

More information

Putting CDISC Standards to Work How Converting to CDISC Standards Early in the Clinical Trial Process Will Make Your CDISC Investment Pay

Putting CDISC Standards to Work How Converting to CDISC Standards Early in the Clinical Trial Process Will Make Your CDISC Investment Pay How Converting to CDISC Standards Early in the Clinical Trial Process Will Make Your CDISC Investment Pay Jon Roth, Vice President, Data Sciences & Biometrics Authorized Trainer for ADaM, CDISC Mark Vieder,

More information

CDISC Standards: Summary

CDISC Standards: Summary Business Case for CDISC Standards: Summary PhRMA-Gartner-CDISC Project September 2006 Carol Rozwell, Gartner Rebecca Daniels Kush, CDISC Ed Helton, SAS Frank Newby, CDISC Tanyss Mason, CDISC Clinical Data

More information

Data standardization and advancing regulatory science

Data standardization and advancing regulatory science Data standardization and advancing regulatory science Yoshiaki Uyama, Ph.D. Pharmaceuticals & Medical Devices Agency (PMDA) Visiting Professor, Graduate School of Medicine, Chiba University Visiting Professor,

More information

Biomarker Data Management in Clinical Trials: Addressing the Challenges of the New Regulatory Landscape

Biomarker Data Management in Clinical Trials: Addressing the Challenges of the New Regulatory Landscape Biomarker Data Management in Clinical Trials: Addressing the Challenges of the New Regulatory Landscape Introduction Biomarkers and specialty labs are core to modern clinical trials.the broad and evergrowing

More information

SAS & Clinical Data Repository Karthikeyan Chidambaram

SAS & Clinical Data Repository Karthikeyan Chidambaram SAS & Clinical Data Repository Karthikeyan Chidambaram Cognizant Technology Solutions, Newbury Park, CA Clinical Data Repository (CDR) Drug development lifecycle consumes a lot of time, money and effort.

More information

Meeting Minutes. CDISC-HL7 Stage I-B January 14-15, :00 am 12:30 pm (EST) HL7 Orlando, FL

Meeting Minutes. CDISC-HL7 Stage I-B January 14-15, :00 am 12:30 pm (EST) HL7 Orlando, FL Meeting Minutes CDISC-HL7 Stage I-B January 14-15, 2009 9:00 am 12:30 pm (EST) HL7 Orlando, FL Attendees / Affiliation ATTENDEES COMPANY 1/14 Q1 1/14 Q2 1/15 Q1 1/15 Q2 Jay Levine FDA X X X X (co-chair)

More information

The Anatomy of Clinical Trials Data: A Beginner s Guide

The Anatomy of Clinical Trials Data: A Beginner s Guide ABSTRACT Paper 1759-2018 The Anatomy of Clinical Trials Data: A Beginner s Guide Venky Chakravarthy, BioPharma Data Services, Ann Arbor, Michigan An audience that wants to learn more about clinical trials

More information

Question and Answer Guide Regarding Notification on Practical Operations of Electronic Study Data Submissions

Question and Answer Guide Regarding Notification on Practical Operations of Electronic Study Data Submissions Administrative Notice April 27, 2015 To: Prefectrual Health Department (Bureau) Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare Question

More information

Aepodia is a team of experts with more than 15 years

Aepodia is a team of experts with more than 15 years Aepodia is a team of experts with more than 15 years experience in early clinical development and translational science with small startup and large global pharmaceutical companies. Aepodia s team has

More information

9th Annual SAS Health Care & Life Sciences Executive Conference

9th Annual SAS Health Care & Life Sciences Executive Conference : An Integrated Platform to Promote Data Exchange, Collaboration, and Advanced Analytics 9th Annual SAS Health Care & Life Sciences Executive Conference 9-10 May 2012 Bernd Doetzkies, Director Informatics

More information

Exploration des données d essais cliniques en utilisant le standard CDISC

Exploration des données d essais cliniques en utilisant le standard CDISC Exploration des données d essais cliniques en utilisant le standard CDISC Florence Kussener French System Engineer Florence.Kussener@jmp.com SAS Institute AGENDA Outcomes of using CDISC standards Case

More information

CDASH 2.0. Berlin Éanna Kiely CDISC Engineer

CDASH 2.0. Berlin Éanna Kiely CDISC Engineer CDASH 2.0 Berlin Éanna Kiely CDISC Engineer 2016-09-13 Agenda CDASH 1.1 & CDASHIG 2.0 CDASH Concepts TAUG Examples Current Regulatory Perspective on CDASH Questions 2 CDASH: CDISC End to End Clinical Data

More information

Electronic Data Submission and Utilization in Japan

Electronic Data Submission and Utilization in Japan PharmaSUG SDE Japan 2018 Electronic Data Submission and Utilization in Japan Hiromi Sugano Biostatistics Reviewer Office of New Drug II / Office of Advanced Evaluation with Electronic Data Pharmaceuticals

More information

CDISC Journal. Organizing and Accelerating the Clinical Research Process from the Beginning: The CDISC Protocol Representation Model and Toolkit

CDISC Journal. Organizing and Accelerating the Clinical Research Process from the Beginning: The CDISC Protocol Representation Model and Toolkit CDISC Journal Clinical Data Interchange Standards Consortium oc tober 2012 Organizing and Accelerating the Clinical Research Process from the Beginning: The CDISC Protocol Representation Model and Toolkit

More information

CDISC Controlled Terminology: Let s Speak the Same Language. CDISC User Group Meeting March 12, 2009

CDISC Controlled Terminology: Let s Speak the Same Language. CDISC User Group Meeting March 12, 2009 CDISC Controlled Terminology: Let s Speak the Same Language CDISC User Group Meeting March 12, 2009 Agenda Key Terminology Objectives Key Drivers Terminology Production and Development Future Plans 2 Terminology

More information

XClinical Software & Services

XClinical Software & Services Fact Sheets XClinical Software & Services XClinical was founded in Munich (Germany) in 2002 with a vision to build a new EDC system leveraging CDISC standards to accelerate the database build and reduce

More information

Electronic Health Records and Clinical Data Interchange Standards. Stephen E. Wilson, Dr.P.H., CAPT USPHS. Director. Division of Biostatistics III

Electronic Health Records and Clinical Data Interchange Standards. Stephen E. Wilson, Dr.P.H., CAPT USPHS. Director. Division of Biostatistics III Electronic Health Records and Clinical Data Interchange Standards Stephen E. Wilson, Dr.P.H., CAPT USPHS Director Division of Biostatistics III Center for Drug Evaluation and Research US Food and Drug

More information

Cross functional standards governance for pharma

Cross functional standards governance for pharma Paper DS08/PP17 Cross functional standards governance for pharma Warwick Benger, GlaxoSmithKline, UK Sheetal Patel, GlaxoSmithKline, UK ABSTRACT The regulatory and standards environment for clinical research

More information

Clinical Data in Business Intelligence

Clinical Data in Business Intelligence Paper DV07 Clinical Data in Business Intelligence Mike Collinson, Oracle Heath Sciences Consulting (HSC), Reading, UK ABSTRACT Clinical organizations are under increasing pressure to execute clinical trials

More information

MANAGING AND INTEGRATING CLINICAL TRIAL DATA: A Challenge for Pharma and their CRO Partners

MANAGING AND INTEGRATING CLINICAL TRIAL DATA: A Challenge for Pharma and their CRO Partners MANAGING AND INTEGRATING CLINICAL TRIAL DATA: A Challenge for Pharma and their CRO Partners Within the Pharmaceutical Industry, nothing is more fundamental to business success than bringing drugs and medical

More information

Disease Specific Data Standards: Case Studies in TB and Cardiology

Disease Specific Data Standards: Case Studies in TB and Cardiology CDISC 2010 Disease Specific Data Standards: Case Studies in TB and Cardiology CDISC Japan Interchange 20 July 2010 Bron Kisler bkisler@cdisc.org CDISC 2010 Presentation Outline Why disease-specific standards?

More information

ambiguous insights through HCL s R&D Transformation limit your business

ambiguous insights through HCL s R&D Transformation limit your business ambiguous insights through HCL s R&D Transformation limit your business Life Sciences industry is undergoing a transformational change - blockbuster patent expirations, global interconnected world, and

More information

Electronic Health Records and Clinical Data Interchange Standards

Electronic Health Records and Clinical Data Interchange Standards Electronic Health Records and Clinical Data Interchange Standards Stephen E. Wilson, Dr.P.H., CAPT USPHS Director Division of Biostatistics III Center for Drug Evaluation and Research US Food and Drug

More information

Clinical Data Acquisition Standards Harmonization (CDASH)

Clinical Data Acquisition Standards Harmonization (CDASH) Clinical Data Acquisition Standards Harmonization () Prepared by: CDISC Team Section Table of Contents Page 1.0 Orientation... 1 1.1 Purpose... 1 1.2 Organization of this Document... 1 1.2.1 General Notes...2

More information

Disclaimers The views expressed are those of the presenter and not necessarily of the FDA With the FDA, as with the stock market, past performance is

Disclaimers The views expressed are those of the presenter and not necessarily of the FDA With the FDA, as with the stock market, past performance is Managing Biometrics Tasks for an ectd Submission 1 Disclaimers The views expressed are those of the presenter and not necessarily of the FDA With the FDA, as with the stock market, past performance is

More information

Trial Summary: The Golden Gate towards a Successful Submission

Trial Summary: The Golden Gate towards a Successful Submission PharmaSUG 2018 - Paper SS-04 Trial Summary: The Golden Gate towards a Successful Submission ABSTRACT Bhargav Koduru, and Girish Kankipati, Seattle Genetics Inc. Trial Summary (TS) has gained importance

More information

LIFE SCIENCE ANALYTICS FRAMEWORK (LSAF)

LIFE SCIENCE ANALYTICS FRAMEWORK (LSAF) PaperTT-15 Incorporating Pinnacle21 With LSAF Sonali Garg, Alexion Pharmaceuticals, New Haven, USA Sandeep Juneja, SAS Institute, Cary, USA Aleksey Vinokurov, Pinnacle21, Plymouth Meeting, USA ABSTRACT

More information

Investigator-Initiated INDs

Investigator-Initiated INDs Investigator-Initiated INDs Marjorie Small, RN, CCRC Office of Clinical Research 23 May 2011 PPHS/IRB Research Grand Rounds Outline of Presentation I. What is an IND? II. Code of Federal Regulations III.

More information

PharmaSUG Paper PO12

PharmaSUG Paper PO12 PharmaSUG 2016 - Paper PO12 CDISC Standards End-to-End: Transitional Hurdles Alyssa Wittle, Chiltern International, King of Prussia, PA Christine McNichol, Chiltern International, King of Prussia, PA Antonio

More information

Controlled Terminology

Controlled Terminology CDISC Italian User Group 16 November 2007 Controlled Terminology Cecilia Moresino Helsinn Healthcare Controlled Terminology A finite set of values that represent the only allowed values for a data item.

More information

Standard for Exchange of Nonclinical Data Implementation Guide: Nonclinical Studies

Standard for Exchange of Nonclinical Data Implementation Guide: Nonclinical Studies Standard for Exchange of Nonclinical Data Implementation Guide: Nonclinical Studies Prepared by the CDISC Standard for Exchange of Nonclinical Data Team Notes to Readers This is the implementation guide

More information

BIOCLINICA CLINICAL DATA MANAGEMENT

BIOCLINICA CLINICAL DATA MANAGEMENT BIOCLINICA CLINICAL DATA MANAGEMENT Achieve faster speed to market, with Bioclinica s best-in-class Electronic Data Capture (EDC) technology and in-house full-service Data Management (DM) services. $ BIOCLINICA

More information

Nice SUPPQUAL Variables to Have Beilei Xu, Merck & Co., Inc., Rahway, NJ Changhong Shi, Merck & Co., Inc., Rahway, NJ

Nice SUPPQUAL Variables to Have Beilei Xu, Merck & Co., Inc., Rahway, NJ Changhong Shi, Merck & Co., Inc., Rahway, NJ Paper RS05 Nice SUPPQUAL Variables to Have Beilei Xu, Merck & Co., Inc., Rahway, NJ Changhong Shi, Merck & Co., Inc., Rahway, NJ ABSTRACT A Supplemental Qualifier (SUPPQUAL) data set is a special Study

More information

Use and Evaluation of Standards for Investigator-Initiated Studies: Preliminary Results

Use and Evaluation of Standards for Investigator-Initiated Studies: Preliminary Results Use and Evaluation of Standards for Investigator-Initiated Studies: Preliminary Results M. Theresa Perry RTRN (DTCC) 2010 AMIA Summit on Clinical Research Informatics March 12-13, 2010 Parc 55 Hotel San

More information

Work with me here...(or there or anywhere): Practical Cloud Collaboration with JMP Clinical for Clinical Trial Data Reviews

Work with me here...(or there or anywhere): Practical Cloud Collaboration with JMP Clinical for Clinical Trial Data Reviews PharmaSUG 2017 - Paper AD07 Work with me here...(or there or anywhere): Practical Cloud Collaboration with JMP Clinical for Clinical Trial Data Reviews ABSTRACT Kelci Miclaus and Drew Foglia, SAS Institute

More information

Paper MA04. Greg Nelson ThotWave Technologies, Cary, North Carolina

Paper MA04. Greg Nelson ThotWave Technologies, Cary, North Carolina Paper MA04 Using SAS 9 in Clinical Research Greg Nelson ThotWave Technologies, Cary, North Carolina Abstract For 30 years SAS has been used in pharmaceutical research settings for data management, analytics

More information

Specific pathologist responses for Standard for Exchange of Nonclinical Data (SEND)

Specific pathologist responses for Standard for Exchange of Nonclinical Data (SEND) J Toxicol Pathol 2017; 30: 201 207 Review Specific pathologist responses for Standard for Exchange of Nonclinical Data (SEND) Atsushi Watanabe 1, 2*, Osamu Kusuoka 1, Norihiro Sato 1, Osamu Nakazono 1,

More information